Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Harvard University
Memory T cells boost the DNA vaccine adjuvant interleukin-2/immunoglobulin
November 6th, 2004
Memory T cells boost the DNA vaccine adjuvant interleukin-2/immunoglobulin. "The development of strategies to augment the immunogenicity of plasmid DNA vaccines is critical for improving their clinical utility. One such strategy involves the coadministration of plasmid cytokine adjuvants with DNA vaccines. Although a large number of plasmid cytokines have shown promise as adjuvants in preclinical animal models, little is known about their expression kinetics and mechanism of action," investigators in the United States report. "We have previously shown that administration of a plasmid encoding the interleukin-2/immunoglobulin (IL-2/Ig) cytokine fusion...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2004-11-06)
|
